Pia Joseph Chedid

Dr. Pia Joseph Chedid

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
RNRana Nassif
Rana Nassif
ECElias Chalhoub
Elias Chalhoub
PCPia Joseph Chedid
Pia Joseph Chedid
MHMargarita Hurtado-Nedelec
Margarita Hurtado-Nedelec
ERElia Raya
Elia Raya
Jamel El BennaJamel El Benna
Jamel El Benna
Metformin (1,1-dimethylbiguanide hydrochloride) is the most commonly used drug to treat type II diabetic patients. It is believed that this drug has several other beneficial effects, such as anti-inflammatory and anticancer effects. Here, we wanted to evaluate the effect of metformin on the production of reactive oxygen species (ROS) by human macrophages. Macrophages are generated in vivo from circulating monocytes depending on the local tissue environment. In vitro proinflammatory macrophages (M1) and anti-inflammatory macrophages (M2) can be generated by culturing monocytes in the presence of different cytokines, such as GM-CSF or M-CSF, respectively. We show that metformin selectively inhibited human monocyte differentiation into proinflammatory macrophages (M1) without inhibiting their differentiation into anti-inflammatory macrophages (M2). Moreover, we demonstrate that, in response to LPS, M2 macrophages produced ROS, which could be very harmful for nearby tissues, and metformin inhibited this process. Interestingly, metformin with LPS induced activation of the adenosine-monophosphate-activated protein kinase (AMPK) and pharmacological activation of AMPK by AICAR, a known AMPK activator, decreased ROS production, whereas the deletion of AMPK in mice dramatically enhanced ROS production in different types of immune cells. These results suggest that metformin exhibits anti-inflammatory effects by inhibiting the differentiation of human monocytes into M1 macrophages and by limiting ROS production by macrophages via the activation of AMPK.

1 February 2012 in The American Journal of Pathology
Verified
Journal Article
Closed access
PCPia Joseph Chedid
Pia Joseph Chedid
MHMargarita Hurtado-Nedelec
Margarita Hurtado-Nedelec
BMBenoit Marion-Gaber
Benoit Marion-Gaber
OBOdile Bournier
Odile Bournier
GHGilles Hayem
Gilles Hayem
JMJean-Claude Marie
Jean-Claude Marie

5 June 2009 in Diabetes
Verified
Journal Article
Open access
RKRim Belharbi Krimi
Rim Belharbi Krimi
PLPhilippe Letteron
Philippe Letteron
PCPia Joseph Chedid
Pia Joseph Chedid
CNCorinne Nazaret
Corinne Nazaret
RDRobert Ducroc
Robert Ducroc
JMJean-Claude Marie
Jean-Claude Marie
OBJECTIVE: An increased expression of RELM-β (resistin-like molecule-β), a gut-derived hormone, is observed in animal models of insulin resistance/obesity and intestinal inflammation. Intestinal sugar absorption is modulated by dietary environment and hormones/cytokines. The aim of this study was to investigate the effect of RELM-β on intestinal glucose absorption. RESEARCH DESIGN AND METHODS: Oral glucose tolerance test was performed in mice and rats in the presence and the absence of RELM-β. The RELM-β action on glucose transport in rat jejunal sacs, everted rings, and mucosal strips was explored as well as downstream kinases modulating SGLT-1 and GLUT2 glucose transporters. RESULTS: Oral glucose tolerance test carried out in rodents showed that oral administration of RELM-β increased glycemia. Studies in rat jejunal tissue indicated that mucosal RELM-β promoted absorption of glucose from the gut lumen. RELM-β had no effect on paracellular mannitol transport, suggesting a transporter-mediated transcellular mechanism. In studies with jejunal mucosa mounted in Ussing chamber, luminal RELM-β inhibited SGLT-1 activity in line with a diminished SGLT-1 abundance in brush border membranes (BBMs). Further, the potentiating effect of RELM-β on jejunal glucose uptake was associated with an increased abundance of GLUT2 at BBMs. The effects of RELM-β were associated with an increased amount of protein kinase C βII in BBMs and an increased phosphorylation of AMP-activated protein kinase (AMPK). CONCLUSIONS: The regulation of SGLT-1 and GLUT2 by RELM-β expands the role of gut hormones in short-term AMPK/protein kinase C mediated control of energy balance.

1 March 2017 in Mucosal Immunology
Verified
Journal Article
Open access
PDF file
PCPia Joseph Chedid
Pia Joseph Chedid
TBT. Boussetta
T. Boussetta
PDP M-C Dang
P M-C Dang
SBS.A. Belambri
S.A. Belambri
VMV. Marzaioli
V. Marzaioli
JMJ-C Marie
J-C Marie
Reactive oxygen species (ROS) produced by the phagocyte NADPH oxidase (NOX2) are required for microbial clearance; however, when produced in excess they exacerbate inflammatory response and injure surrounding tissues. NOX2 is a multicomponent enzyme composed of membrane-associated cytochrome b588 and cytosolic components p47phox, p67phox, p40phox, and rac1/2. We investigated whether vasoactive intestinal peptide (VIP), an endogenous immune-modulatory peptide, could affect ROS production by NOX2 in primary human phagocytes. VIP did not modulate basal ROS production by phagocytes, but it inhibited monocyte and not neutrophil ROS production in response to the bacterial peptide N-formyl-methionyl-leucyl-phenylalanine (fMLF). The action of VIP was essentially mediated by high-affinity G-protein coupled receptors VPAC1 as its specific agonist, [ALA11,22,28]VIP, mimicked VIP-inhibitory effect, whereas the specific VPAC1 antagonist, PG97-269, blunted VIP action. Further, we showed that VIP inhibited fMLF-induced phosphorylation of ERK1/2 (extracellular signal–regulated kinase 1/2), p38MAPK (p38 mitogen-activated protein kinase) pathways, and phosphorylation of p47phox on Ser345 residue. Also, VIP exerted an anti-inflammatory effect in a model of carrageenan-induced inflammation in rats. We thus found that VIP exerts anti-inflammatory effects by inhibiting the “MAPK–p47phox phosphorylation–NOX2 activation” axis. These data suggest that VIP acts as a natural anti-inflammatory agent of the mucosal system and its analogs could be novel anti-inflammatory molecules.

8 May 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SSSara Saleh
Sara Saleh
PCPia Joseph Chedid
Pia Joseph Chedid
Background: Barriers to childhood immunization in Lebanon are multifaceted. While Lebanon has historically maintained high immunization coverage, recent socio-economic challenges and recurrent political crisis have strained the healthcare system, leading to decreased vaccination rates. The knowledge, attitudes, and practices (KAP) of mothers play a key role in determining whether their children receive recommended immunizations. The aim of this study was to assess the KAP of Lebanese mothers regarding childhood immunization and to identify potential barriers to vaccination in children. Methods: A cross-sectional study was conducted among Lebanese mothers with children aged between zero days to 5 years old. A stratified random sampling method was used and a structured questionnaire was administered to collect data on KAP regarding childhood immunization. Descriptive statistics were performed. Chi-square test and linear regression were used to assess the association between KAP and sociodemographic factors with significance set at p < 0.05. Results: Most mothers demonstrated good knowledge (86.3%) and positive attitudes (94.8%) toward vaccination. However, only 43.3% exhibited good vaccination practices. Significant disparities were observed in rural regions such as Beqaa, where mothers had the lowest education levels, the highest rates of poor knowledge (11.9%), and the lowest vaccination practice scores (32.7%). Employment was significantly associated with higher knowledge scores (p = 0.002, 95% CI: -1.42 to -0.33), while household income was significantly associated with attitudes (p = 0.009, 95% CI: -0.96 to -0.13) and vaccination practices (p = 0.002, 95% CI: -0.48 to -0.11). Vaccine unavailability and cost were frequently cited as barriers, particularly in rural regions. Conclusions: Discrepancy between knowledge and attitude v/s practice suggests that a number of barriers prevent mothers from translating their good knowledge and positive attitude into action. Significant regional disparities exist, with rural areas like Beqaa facing the greatest challenges. Strengthening vaccine accessibility, implementing targeted educational interventions, and increasing governmental support are critical to improving immunization coverage nationwide.